|
|
Volumn 21, Issue 3, 2003, Pages 217-
|
|
US authorities uphold suspension of SCID gene therapy
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADVISORY COMMITTEE;
ARTICLE;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CLINICAL TRIAL;
COMBINED IMMUNODEFICIENCY;
DRUG APPROVAL;
ETHICS;
FRANCE;
GENE THERAPY;
GENETICS AND REPRODUCTION;
HEALTH CARE ORGANIZATION;
HUMAN;
LEGAL APPROACH;
LEGAL ASPECT;
LEUKEMIA;
METHODOLOGY;
ORGANIZATION AND MANAGEMENT;
UNITED STATES;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
GENETICS AND REPRODUCTION;
LEGAL APPROACH;
ADVISORY COMMITTEES;
CLINICAL TRIALS;
DRUG APPROVAL;
FRANCE;
GENE THERAPY;
HUMANS;
LEUKEMIA;
NATIONAL INSTITUTES OF HEALTH (U.S.);
SEVERE COMBINED IMMUNODEFICIENCY;
UNITED STATES;
|
|
EID: 0042028565
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0303-217 Document Type: Note |
|
Times cited : (13)
|
|
References (0)
|